Both stocks run through our valuation models. Here is how Bactiquant AS (BACTIQ) and Veralto (VLTO) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Veralto as the less overvalued of the two: Bactiquant AS trades at DKK 2.30 versus a fair value of DKK 0.44 (-81%), while Veralto trades at $98.34 versus $69.11 (-30%).
Bactiquant AS
BACTIQ.CO · DKK · Industrials
-81%
upside to fair value
overvalued
PriceDKK 2.30
Fair ValueDKK 0.44
Quality37/100
Veralto
VLTO · USD · Industrials
-30%
upside to fair value
overvalued
Price$98.34
Fair Value$69.11
Quality71/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Bactiquant ASVeralto
Valuation
—P/E (TTM)23.7×
1.62×P/S (TTM)4.00×
0.78×P/B7.20×
—EV/EBITDA16.2×
—PEG2.70×
—Dividend yield0.5%
—Dividend per share$0.48
Profitability
-166%Net margin17%
-146%Operating margin24%
-154%Return on equity36%
-37%Return on assets11%
Growth
1%Revenue growth (YoY)7%
-12.4%Avg. growth/yr (3Y)4.2%
8.7%Avg. growth/yr (5Y)4.8%
Balance & size
0.39×Debt / equity0.64×
$14MMarket cap$22B
expensiveGrowth qualityhealthy
Veralto leads: 4 to 6 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Bactiquant ASof which business quality 39 · market factors 26Veraltoof which business quality 70 · market factors 54
ProfitabilityMargins and returns on capital today
3
75
Quality GrowthAre margins and returns improving?
74
36
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
78
72
Low VolatilityCalm price path (market factor)
49
80
MomentumPrice trend over the last 3–12 months (market factor)
14
43
52W MomentumDistance to the 52-week high (market factor)
20
41
Net IssuanceBuybacks instead of dilution
0
77
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Bactiquant AS
Dividend DiscountDKK 0.42
Asset-BasedDKK 0.31
3 of 3 models see the stock below the current price.
Veralto
DCF Models$65.58
Earnings-Based$47.47
Dividend Discount$6.75
Multiples$64.44
Asset-Based$8.47
Growth DCF$56.57
Economic Profit$46.75
Growth Earnings$65.88
25 of 25 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Bactiquant AS
Bear DKK 0.26Fair Value DKK 0.44Bull DKK 0.63
DKK 2.30 = current price (white tick)
Veralto
Bear $46.91Fair Value $69.11Bull $87.04
$98.34 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Bactiquant AS · Industrials
Quality score37 · bottom 25%
Fair value upside-81% · bottom 25%
Veralto · Industrials
Quality score71 · Top 25%
Fair value upside-30% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees Veralto as the less overvalued of the two: Bactiquant AS trades at DKK 2.30 versus a fair value of DKK 0.44 (-81%), while Veralto trades at $98.34 versus $69.11 (-30%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
